VictorMichaelAquinoMD

Clinical Trials

• Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors Start of enrollment: 1998 Aug 01

  Completed

  Phase 1

• Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia Start of enrollment: 1999 Jan 01

  Completed

  Phase 2

• Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01

  Completed

  Phase 1, Phase 2

• Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01

  Completed

  Phase 3

• Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) Start of enrollment: 2008 Aug 01

  Completed

  Phase 2

• Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02

  Enrolling by invitation

• Patients Treated for SCID (1968-Present) Start of enrollment: 2011 May 15

  Enrolling by invitation

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01

  Recruiting

  Roles: Contact, Principal Investigator

• Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21

  Completed

  Phase 3

• Multimodal Physical Activity for the Elderly Start of enrollment: 2008 Jan 01

  Completed

  Not Applicable

• Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24

  Completed

  Phase 2

• Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 Start of enrollment: 2014 Feb 02

  Completed

• Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 Start of enrollment: 2014 Jun 01

  Enrolling by invitation

• Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy Start of enrollment: 2018 Oct 11

  Terminated

  Phase 2

  Roles: Contact

• A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases Start of enrollment: 2021 Jul 14

  Recruiting

  Phase 2

  Roles: Contact

• Conditioning SCID Infants Diagnosed Early Start of enrollment: 2018 Oct 22

  Recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant Start of enrollment: 2020 Nov 13

  Recruiting

  Not Applicable

  Roles: Contact, Principal Investigator

• Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

  Available

  Roles: Contact, Sponsor-Investigator

• Join now to see all